{"id":501639,"date":"2021-06-08T07:07:03","date_gmt":"2021-06-08T11:07:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/"},"modified":"2021-06-08T07:07:03","modified_gmt":"2021-06-08T11:07:03","slug":"angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/","title":{"rendered":"AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System<\/b><\/p>\n<p class=\"bwalignc\"><b>Company to Hold Fiscal Fourth Quarter and Fiscal Year 2021 Earnings Conference Call and Virtual Investor and Technology Day on July 13, 2021<\/b><\/p>\n<p>LATHAM, N.Y.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nAngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the AlphaVac Mechanical Thrombectomy System, an off-circuit, multi-purpose mechanical aspiration thrombectomy device for the non-surgical removal of thrombi or emboli from the vasculature.\n<\/p>\n<p>\nAngioDynamics continues to anticipate the commercial release of the AlphaVac System in the second half of calendar year 2021.\n<\/p>\n<p>\nThe Company will report financial results for the fourth quarter and fiscal year 2021 before the market open on Tuesday, July 13, 2021. The Company\u2019s management will host a conference call at 8:00 a.m. ET to discuss the results.\n<\/p>\n<p>\nManagement will also host a virtual Investor and Technology Day following its earnings conference call at 9:30 a.m. ET that same day.\n<\/p>\n<p>\nFurther details, including registration, webcast, and dial-in information, will be provided at a later date.\n<\/p>\n<p><b>About AngioDynamics, Inc.<\/b><\/p>\n<p>\nAngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics\u2019 diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products and venous products. For more information, visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.angiodynamics.com&amp;esheet=52441817&amp;newsitemid=20210608005400&amp;lan=en-US&amp;anchor=www.angiodynamics.com&amp;index=1&amp;md5=e6837111feb491d62dc07887ea44be9c\">www.angiodynamics.com<\/a>.\n<\/p>\n<p>\nAngioDynamics and AlphaVac are trademarks and\/or registered trademarks of AngioDynamics, Inc., an affiliate or subsidiary.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005400r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210608005400\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210608005400\/en\/<\/a><\/span><\/p>\n<p><b>Investor Relations:<br \/>\n<\/b><\/p>\n<p>AngioDynamics, Inc.<br \/>\n<br \/>Stephen Trowbridge<br \/>\n<br \/>518-795-1408<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:strowbridge@angiodynamics.com\">strowbridge@angiodynamics.com<\/a><\/p>\n<p><b>Media:<\/b><\/p>\n<p>\nAngioDynamics, Inc.<br \/>\n<br \/>Saleem Cheeks<br \/>\n<br \/>518-795-1174<br \/>\n<br \/><a rel=\"nofollow\" href=\"mailto:scheeks@angiodynamics.com\">scheeks@angiodynamics.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> New York United States North America<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Surgery Medical Devices Health Cardiology Oncology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210608005400\/en\/664620\/3\/ANGO_-_Logo.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System Company to Hold Fiscal Fourth Quarter and Fiscal Year 2021 Earnings Conference Call and Virtual Investor and Technology Day on July 13, 2021 LATHAM, N.Y.&#8211;(BUSINESS WIRE)&#8211; AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the AlphaVac Mechanical Thrombectomy System, an off-circuit, multi-purpose mechanical aspiration thrombectomy device for the non-surgical removal of thrombi or emboli from the vasculature. AngioDynamics continues to anticipate the commercial release of the AlphaVac System in the second half of calendar year 2021. The Company will report &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-501639","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System Company to Hold Fiscal Fourth Quarter and Fiscal Year 2021 Earnings Conference Call and Virtual Investor and Technology Day on July 13, 2021 LATHAM, N.Y.&#8211;(BUSINESS WIRE)&#8211; AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the AlphaVac Mechanical Thrombectomy System, an off-circuit, multi-purpose mechanical aspiration thrombectomy device for the non-surgical removal of thrombi or emboli from the vasculature. AngioDynamics continues to anticipate the commercial release of the AlphaVac System in the second half of calendar year 2021. The Company will report &hellip; Continue reading &quot;AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-08T11:07:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005400r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System\",\"datePublished\":\"2021-06-08T11:07:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\\\/\"},\"wordCount\":323,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210608005400r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\\\/\",\"name\":\"AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210608005400r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-06-08T11:07:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210608005400r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210608005400r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/","og_locale":"en_US","og_type":"article","og_title":"AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System - Market Newsdesk","og_description":"AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System Company to Hold Fiscal Fourth Quarter and Fiscal Year 2021 Earnings Conference Call and Virtual Investor and Technology Day on July 13, 2021 LATHAM, N.Y.&#8211;(BUSINESS WIRE)&#8211; AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the AlphaVac Mechanical Thrombectomy System, an off-circuit, multi-purpose mechanical aspiration thrombectomy device for the non-surgical removal of thrombi or emboli from the vasculature. AngioDynamics continues to anticipate the commercial release of the AlphaVac System in the second half of calendar year 2021. The Company will report &hellip; Continue reading \"AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-08T11:07:03+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005400r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System","datePublished":"2021-06-08T11:07:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/"},"wordCount":323,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005400r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/","name":"AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005400r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-06-08T11:07:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005400r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210608005400r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/angiodynamics-receives-510k-clearance-for-alphavac-mechanical-thrombectomy-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"AngioDynamics Receives 510(k) Clearance for AlphaVac Mechanical Thrombectomy System"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/501639","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=501639"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/501639\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=501639"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=501639"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=501639"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}